[1]
V, R. , Y, R.P. and A, L.R. 2022. Comparative In Vivo Evaluation of Marketed and Optimized Formulations of Teneligliptin and Metformin Bilayered Tablets. Current Trends in Biotechnology and Pharmacy. 16, 3s (Oct. 2022), 96–102. DOI:https://doi.org/10.5530/ctbp.2022.3s.68.